Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.
about
Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosineStrand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitroAssociation of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infectionATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix proteinGenomic flexibility of human endogenous retrovirus type KRevisiting HIV-1 uncoating.Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA.Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cellEndogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.Role of Vif in human immunodeficiency virus type 1 reverse transcriptionDiscontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free systemIntravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.When is it time for reverse transcription to start and go?Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.Implications of the nucleocapsid and the microenvironment in retroviral reverse transcription.Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.Role of Vif in stability of the human immunodeficiency virus type 1 coreIncreasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies.Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore.
P2860
Q28368041-D06D5A31-54BC-457C-AA2C-F02F3B8E0339Q28475697-48D39E8F-A428-47C2-A2B8-C1A5C5A0097AQ28646834-E3376CDA-986C-465D-8A83-29CBED37A046Q33755116-D3A5452F-0000-477A-81DA-46F24468181FQ33803814-2557BD0D-7A13-4715-A656-470875A5B7D5Q34045624-B6CDB5A6-3283-41B6-86FB-A35887A06C37Q34059466-3A9E7A93-ABFF-42AF-9FA7-F221E82101F3Q34387732-483D8275-E1F8-4E89-857E-E7EE7FBF8859Q35823493-C0869B46-5268-4EEB-BBEF-C564974526D6Q35840793-4E95434D-61EB-4400-A347-39B83CC465A1Q35859899-46F183E6-E9E6-4278-9CD4-49F6AA52D632Q35873743-2D6CE76F-4ADA-4E26-9BD4-F3BB1BC7A666Q36548782-53F24DB2-05D2-441B-8AD6-40E8193D61E9Q36637426-EF000FF9-EEC3-43CC-B9EE-36A804DF4146Q37130269-07BE27C4-8BC6-445B-9CF6-6B56CCDC8966Q37242308-48AA3B91-1A47-4813-A099-058D78B370BCQ37945202-AD640895-8FEE-452F-9414-5FDB8570050FQ38290032-3A4FDB9C-1763-49BE-A1C5-CF6AD57272A2Q38911884-116ABA63-12A4-4901-B79A-8D9550E86F05Q39597709-D64A3BCA-4B4F-4929-AEE1-E85D4C1DD04AQ39870518-478804ED-3A52-496F-9990-316D62F9D27BQ39880094-FEB5E5F0-65AB-4AD3-AEE6-BED167829BE2Q40039220-F0312AC6-0254-402F-8C5E-E41B51A8199BQ41914326-F000F6EC-037C-4D41-B233-7A112E28A6C7
P2860
Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Equine infectious anemia virus ...... everse transcriptase reaction.
@en
type
label
Equine infectious anemia virus ...... everse transcriptase reaction.
@en
prefLabel
Equine infectious anemia virus ...... everse transcriptase reaction.
@en
P2860
P1433
P1476
Equine infectious anemia virus ...... everse transcriptase reaction.
@en
P2093
Borroto-Esoda K
P2860
P304
P407
P577
1991-04-01T00:00:00Z